Comparative Pharmacology
Head-to-head clinical analysis: IMAGENT versus LUMASON.
Peer-Reviewed Evidence
Head-to-head clinical analysis: IMAGENT versus LUMASON.
IMAGENT vs LUMASON
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Imagent is a microbubble-based ultrasound contrast agent. It consists of perflutren (octafluoropropane) gas-filled microbubbles stabilized by phospholipids. The microbubbles oscillate and increase echogenicity in blood, enhancing ultrasound signal and imaging of cardiac structures and blood flow. Its mechanism does not involve active pharmacological action but rather physical acoustic enhancement.
LUMASON (sulfur hexafluoride lipid-type A microspheres) is an ultrasound contrast agent that consists of gas-filled microspheres. After intravenous injection, the microspheres enhance the ultrasound signal by increasing the backscatter of ultrasound waves, thereby improving the visualization of cardiac chambers, endocardial borders, and vascular structures.
0.1 mL/kg intravenous bolus over 1-2 seconds, up to a maximum of 10 mL. Repeat dose once if needed after 30 minutes.
0.5 mL intravenous bolus injection, followed by 5 mL saline flush. May repeat once if needed.
None Documented
None Documented
Terminal elimination half-life is 1.2 hours in patients with normal renal function; prolonged in renal impairment (up to 8 hours in severe impairment).
Terminal elimination half-life is approximately 2 hours (range 1.5–2.5 hours) after intravenous administration, reflecting rapid clearance and supporting use as a diagnostic agent without significant accumulation.
Primarily renal excretion (95% unchanged via glomerular filtration); minimal biliary/fecal (<5%).
Primarily renal; >90% excreted unchanged in urine within 24 hours. Fecal elimination is negligible (<1%).
Category C
Category C
Ultrasound Contrast Agent
Ultrasound Contrast Agent